LINEADNA

What this means for you

This application is over — abandoned 20 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

90086064

Mark type

Stylized text

Filed

31 Jul 2020

Published for opposition

22 Dec 2020

Abandoned

20 Mar 2023

Attorney of record

Jon M. Gibbs

Goods and services

• Class 001 — Chemicals: Biological preparations for use in industry and science; nucleic acid for laboratory use
• Class 005 — Pharmaceuticals: Biological preparations for the treatment of cancer; nucleic acid sequences and chemical reagents for medical and veterinary purposes
• Class 040 — Treatment of materials: Manufacturing of DNA expression vectors for others
• Class 042 — Scientific and technological services: Scientific research; biotechnology research and development; biological research; biomedical research; research and development services in the field of DNA based medications and therapies; DNA expression vector design and development for others; biotechnology and clinical research and development of DNA based medications and therapies

Owner

• LineaRX, Inc., Stony Brook, NY, US
• LineaRX, Inc., Stony Brook, NY, US

Prosecution history

• 20 Mar 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 20 Mar 2023 — ABANDONMENT - NO USE STATEMENT FILED
• 18 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 16 Aug 2022 — SOU EXTENSION 3 GRANTED
• 16 Aug 2022 — SOU EXTENSION 3 FILED
• 16 Aug 2022 — SOU TEAS EXTENSION RECEIVED
• 17 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 15 Feb 2022 — SOU EXTENSION 2 GRANTED
• 15 Feb 2022 — SOU EXTENSION 2 FILED
• 15 Feb 2022 — SOU TEAS EXTENSION RECEIVED
• 06 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 04 Aug 2021 — SOU EXTENSION 1 GRANTED
• 04 Aug 2021 — SOU EXTENSION 1 FILED
• 04 Aug 2021 — SOU TEAS EXTENSION RECEIVED
• 16 Feb 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT